Acute Ischemic Stroke

Chan1, Albers

  • 1Stanford Stroke Center, 701 Welch Road, Building B, Suite 325, Palo Alto, CA 94304-1705, USA.

Insights

Rapid evaluation and treatment are crucial for acute ischemic stroke patients. Intravenous t-PA within 3 hours is recommended for eligible patients, with careful risk-benefit assessment. Aspirin is an alternative for non-eligible individuals.

Area of Science:

  • Neurology
  • Emergency Medicine
  • Cardiovascular Research

Background:

  • Acute ischemic stroke requires immediate medical attention for optimal outcomes.
  • Timely administration of thrombolytic therapy can significantly improve patient prognosis.
  • Established guidelines exist for the use of thrombolytics and anticoagulants in stroke management.

Purpose of the Study:

  • To outline the recommended evaluation and treatment protocols for acute ischemic stroke patients.
  • To emphasize the importance of adhering to established treatment guidelines for t-PA administration.
  • To provide guidance on alternative therapies and supportive care for stroke patients.

Main Methods:

  • Review of current clinical guidelines and research findings on acute ischemic stroke management.
  • Analysis of eligibility criteria and risk-benefit considerations for intravenous thrombolysis (t-PA).
  • Assessment of alternative pharmacological interventions, including aspirin and heparin, for stroke patients.

Main Results:

  • Intravenous t-PA within 3 hours of symptom onset is the primary recommended treatment for eligible acute ischemic stroke patients.
  • Informed consent regarding the risk of symptomatic cerebral hemorrhage is essential prior to t-PA administration.
  • Aspirin is recommended for patients ineligible for t-PA, while heparin has specific indications and is not a standard treatment.
  • Low-dose subcutaneous heparin is advised for deep vein thrombosis prophylaxis in immobilized patients.
  • Management by a dedicated stroke team facilitates prompt diagnosis, treatment, and rehabilitation initiation.

Conclusions:

  • Prompt transport and evaluation are critical for acute ischemic stroke patients.
  • Strict adherence to the NINDS study protocol for t-PA optimizes the risk-benefit ratio.
  • A multidisciplinary approach and collaboration with stroke centers enhance patient care and outcomes.

Related Concept Videos

Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...